Ertugliflozin, a SGLT-2 Inhibitor, Guards Against Thioacetamide-induced Liver Fibrosis: The Nrf2/HO-1 and TLR4/ TGF-β1 Pathways
Hassan, N., Kamel, G., Fayed, H., Korany, R., Ramadan, A. (2025). Ertugliflozin, a SGLT-2 Inhibitor, Guards Against Thioacetamide-induced Liver Fibrosis: The Nrf2/HO-1 and TLR4/ TGF-β1 Pathways. EKB Journal Management System, 10(3), 34-47. doi: 10.21608/javs.2025.372525.1573
Nourhan Hussien Hassan; Gehan M. Kamel; Hany M. Fayed; Reda M.S. Korany; Amer Ramadan. "Ertugliflozin, a SGLT-2 Inhibitor, Guards Against Thioacetamide-induced Liver Fibrosis: The Nrf2/HO-1 and TLR4/ TGF-β1 Pathways". EKB Journal Management System, 10, 3, 2025, 34-47. doi: 10.21608/javs.2025.372525.1573
Hassan, N., Kamel, G., Fayed, H., Korany, R., Ramadan, A. (2025). 'Ertugliflozin, a SGLT-2 Inhibitor, Guards Against Thioacetamide-induced Liver Fibrosis: The Nrf2/HO-1 and TLR4/ TGF-β1 Pathways', EKB Journal Management System, 10(3), pp. 34-47. doi: 10.21608/javs.2025.372525.1573
Hassan, N., Kamel, G., Fayed, H., Korany, R., Ramadan, A. Ertugliflozin, a SGLT-2 Inhibitor, Guards Against Thioacetamide-induced Liver Fibrosis: The Nrf2/HO-1 and TLR4/ TGF-β1 Pathways. EKB Journal Management System, 2025; 10(3): 34-47. doi: 10.21608/javs.2025.372525.1573